Recent Finacing
Recent Raise
Tempo Therapeutics, a clinical-stage regenerative medicine company, develops MAP injectable microporous hydrogel scaffolds to enable immediate tissue ingrowth, reduce foreign-body inflammation, and promote vascularized tissue formation for surgical repair.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
